Millennium Management’s CinCor Pharma, Inc. Common Stock CINC Stock Holding History

Millennium Management’s Portfolio CINC Stock Details CINC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-228,773	Closed	-$2.81M	–	7350
2022 Q4	$2.81M	Buy	+228,773	New	+$5.45M	﹤0.01%	3271
2022 Q2	–	Sell	-12,000	Closed	-$210K	–	7768
2022 Q1	$210K	Buy	+12,000	New	+$246K	﹤0.01%	5802

Millennium Management's CINC Position: Q1 2023 in Review

Millennium Management sold out of CinCor Pharma, Inc. Common Stock (CINC) in Q1 2023, closing a stake of 228,773 shares — an estimated $2.81M sold.

Millennium Management first reported a position in CINC in Q1 2022 and held it in 2 quarters. The position peaked at $2.81M in Q4 2022. 0 funds tracked by Wall St. Rank hold CINC as of Q1 2023.

Millennium Management reported no remaining CinCor Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Millennium Management sold 228,773 CinCor Pharma, Inc. Common Stock shares in Q1 2023, an estimated $2.81M.
Millennium Management first reported a position in CinCor Pharma, Inc. Common Stock in Q1 2022 and held it in 2 quarters.
Millennium Management's CinCor Pharma, Inc. Common Stock position peaked at $2.81M in Q4 2022.
0 funds tracked by Wall St. Rank held CinCor Pharma, Inc. Common Stock as of Q1 2023.

Based on Millennium Management's 13F filing for Q1 2023, filed 15 May 2023.